Draupnir Bio Funding: $13M Raised, Investors & Rounds
Draupnir Bio is based in Copenhagen, Denmark. It has raised $13M in total funding.
Draupnir Bio funding overview
Draupnir Bio is based in Copenhagen, Denmark. Draupnir Bio has raised $13M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Investors on record include MP Healthcare, Export and Investment Fund of Denmark, Gilde Healthcare Partners, Inkef Capital, Novo Holdings. 5 distinct backers are named across the disclosed rounds.
Draupnir Bio at a glance
Total raised
$13M
Headquarters
Copenhagen, Denmark
Notable investors
MP Healthcare, Export and Investment Fund of Denmark, Gilde Healthcare Partners, Inkef Capital, Novo Holdings
Frequently asked about Draupnir Bio funding
How much has Draupnir Bio raised?
Draupnir Bio has raised $13M in total disclosed funding across the rounds on record.
Who has invested in Draupnir Bio?
MP Healthcare, Export and Investment Fund of Denmark, Gilde Healthcare Partners, Inkef Capital, Novo Holdings are named among the investors backing Draupnir Bio.
What was the latest Draupnir Bio funding round?
No round stage has been disclosed for Draupnir Bio.
Where is Draupnir Bio based?
Draupnir Bio is based in Copenhagen, Denmark.
Every Draupnir Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Copenhagen at a similar stage.
